SELEXIS
Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients.
SELEXIS
Industry:
Biotechnology Health Diagnostics
Founded:
2001-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.selexis.com
Total Employee:
11+
Status:
Active
Contact:
(022) 308-9360
Email Addresses:
[email protected]
Total Funding:
67.48 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Current Employees Featured
Founder
Investors List
Eurostars
Eurostars investment in Grant - Selexis
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Selexis
Newest Events participated
Participated in Biotech Week Boston 2019
on 2019-09-10 as sponsor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as sponsor
Participated in Viral Safety 2017
on 2017-04-25 as sponsor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as sponsor
Official Site Inspections
http://www.selexis.com
- Host name: 199.60.103.226
- IP address: 199.60.103.226
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Selexis"
JSR Life Sciences Announces Operational Consolidation …
May 31, 2023 KBI’s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers. Sunnyvale, Calif. -- (May 31, 2023) -- JSR Life Sciences today announced that …See details»
Contract Development Manufacturing Organization - Selexis SA
Our global partners are utilizing Selexis technologies to advance more than 160 drug products in clinical development and the manufacture of 10 commercial products. As part of a …See details»
KBI Biopharma, Selexis SA Merge as One Organization
Jun 5, 2023 KBI Biopharma, Inc., a contract development and manufacturing organization (CDMO), and Selexis SA, a cell line development company, are consolidating as one organization under the KBI Biopharma name. The fusion …See details»
JSR Life Sciences Announces Operational Consolidation of KBI …
May 31, 2023 “The fusion of KBI and Selexis as one business advances KBI into an exciting strategic growth phase,” said Tim Lowery, President of JSR Life Sciences. “This natural …See details»
Selexis SA - LinkedIn
KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and ...See details»
Selexis SA and KBI Biopharma now operate as one …
Nov 15, 2024 Selexis, an EFPL startup, was founded in 2001 before being acquired by the Japanese group JSR Life Sciences. KBI Biopharma, another company owned by JSR, inaugurated its factory in 2022 at Plan les Ouates in …See details»
Selexis - Crunchbase Company Profile & Funding
Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the …See details»
JSR Life Sciences, KBI Biopharma, Selexis Overview
July 27, 2022 USING INNOVATION TO DE-RISK AND ACCELERATE THE DISCOVERY AND DEVELOPMENT OF NEW THERAPEUTICS. JSR Life Sciences brings together the best-in …See details»
JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer ...
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development & biomanufacturing services to pharmaceutical …See details»
Newsroom | Selexis SA
Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences …See details»
Selexis SA - Crunchbase Company Profile & Funding
Organization. Selexis SA . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Selexis SA operates as a global life science company. Acquired by . ...See details»
Selexis and KBI Biopharma Enter into Agreements with Immatics …
Jun 30, 2021 More information is available at www.selexis.com. About KBI Biopharma, Inc. KBI Biopharma, a JSR Life Sciences company, is an award-winning biopharmaceutical contract …See details»
Selexis Names Biopharmaceutical Executive Dirk Lange as New …
Oct 16, 2020 Company Inquiries for Selexis Robert Meister Head, Corporate Communications +1 602-953-1716 [email protected] Contacts Media Inquiries for Selexis Mike Beyer …See details»
USING INNOVATION TO DE-RISK ACCELERATE THE DISCOVERY …
Contract Research Organization Crown Bioscience offers preclinical drug discovery and development services including translational platforms to advance oncology, immuno-oncology …See details»
Great Place to Work® Designates Selexis as a Best Workplace in ...
Geneva, Switzerland, May 11, 2022 – Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work® has designated the Company among the “Best Workplaces …See details»
Selexis Company Profile - Office Locations, Competitors ... - Craft
Selexis is a company engaged in mammalian cell line development technologies. It focuses on molecular biology, cellular physiology, and genetic engineering. The company serves drug …See details»
Selexis and KBI Biopharma Enter into Agreements with Immatics …
Jun 29, 2021 Contacts. Media Inquiries for Selexis and KBI Laura Morgan Sam Brown Inc. +1 951-333-9110 [email protected] Company Inquiries for Selexis Robert Meister …See details»
USING INNOVATION TO DE-RISK AND ACCELERATE THE …
Contract Research Organization Crown Bioscience offers preclinical drug discovery and development services including translational platforms to advance oncology, immuno-oncology …See details»
CAPABILITIES - KBI Biopharma
The Selexis CHO-M genome is entirely sequenced to provide you fully traceable cell lines. CAPABILITIES selexis.com Updated 2H 2022 Scaffold Expression Diversity With the …See details»